Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹60 Cr₹58 Cr₹46 Cr₹58 Cr₹96 Cr

What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?

The latest Total Non-Current Liabilities ratio of VENUS REMEDIES is ₹60 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹60 Cr
Mar2023₹58 Cr
Mar2022₹46 Cr
Mar2021₹58 Cr
Mar2020₹96 Cr

How is Total Non-Current Liabilities of VENUS REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹60 Cr
2.89
Mar2023 ₹58 Cr
26.60
Mar2022 ₹46 Cr
-20.94
Mar2021 ₹58 Cr
-39.34
Mar2020 ₹96 Cr -

Compare Total Non-Current Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹391.3 Cr -3.2% -10.4% -12.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,352.0 Cr 1.7% -4.7% 48.8% Stock Analytics
DIVIS LABORATORIES ₹159,265.0 Cr 4.4% 3.1% 66% Stock Analytics
CIPLA ₹120,035.0 Cr -0.9% -1.7% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,286.0 Cr -1% -8.9% 6.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,461.4 Cr -1% -4% 48.4% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-3.2%

-10.4%

-12.7%

SENSEX

1.8%

-2.5%

19.9%


You may also like the below Video Courses